CLL cells become resistant to a broad range of chemotherapeutic drugs after CD40 stimulation, and previous studies have demonstrated that Bcl-XL plays an important role in resistance to ABT-737 and ABT-1993,12. This evidence concerns the gene BCL2L1 and B-cell chronic lymphocytic leukemia.